Member Info for Nolupus

Whilst everyone is entitled to their own opinions, not everyone is entitled to give advice on buying/selling shares !
One would be WISE to know the difference between a pumper/dumper who changes his spots according to his buy/sell interests …

Sad sad and shame on you ..

Very encouraging data from Faron which will need further confirmations in a larger cohort .

As with all biotechs, one has to be patient as the road to market is a long one

Xviolet,

It’s extremely hard to understand the financials as they are made up mostly of Landstead deals and therefore depending on the SP .. This WIN win situation is seemingly a very good deal for Landstead , as they make money even if the SP crashes and make even more if the SP rises , yet IMM lose their shirts if the SP crashes …

As for the initial Avion agreement which specified that they would fund the P3 trial UPTO $25 million well there is the crux .. Will they fund the P2 trial or not ??
Only time will tell …

Dallo,

I fail to see how the cash runway is projected to the end of 2023 with landstead payments being so low for months now … The SP will need to move up Very Sharply , imo
Anyway we know how IMM’s projections have worked out in the past …

Great result..with more to come , imo

Bottom drawer still

Just waiting on the rerate as the potential is not reflected in the SP .. wonder why TB is keeping this under the radar ?

Thanks for the link …

Jefferies conference went well , I believe

Patience is necessary when one is invested in biotechs …imo

But everyone to their own .

Lambo222,

Do you enjoy giving shareholders a kick in their private parts whilst they are on the ground ??

What goes around comes around !

Wildtiger,

Another paper ‘ research « paid for by IMM , whilst good reading is worth what it’s worth …

Lambo222,

Your game is quite clear since the beginning..( I don’t even need to say more )

Sad ..

Woodstock1970,

Have you joined the bash club ?
We are used to the duo , kingalf and radar so why not a treesome :-)

Thé market seems to have drawn a support level at 8 million MC ..

Let’s see what happens next …

Working on pace ..not haste

P.S.

COPD is the third largest cause of death worldwide ..

We should not forget COPD, imo

A few facts and figures …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. More than 12.5 million people have been diagnosed with COPD in the United States, but millions more may have the disease without even knowing it. COPD causes serious long-term disability and early death.

There is no cure for COPD, but early diagnosis and treatment are important to slow the progression of symptoms and reduce the risk of flare-ups. COPD treatment can alleviate symptoms, decrease the frequency and severity of exacerbations, and increase exercise tolerance. Treatments include stopping smoking, inhalers and tablets, pulmonary rehabilitation, surgery or a lung transplant.

Dallo,

Don’t you think I know the difference between the two ?
When I state one , it’s not the other :-)

Dallo,

P.s.

I would be more inclined to watch for further developments from across the channel …let’s wait and see ..

Slowly but surely …

Thanks Nextlink